Compare SCCO & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCCO | MCK |
|---|---|---|
| Founded | 1952 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Other Pharmaceuticals |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.3B | 101.9B |
| IPO Year | N/A | N/A |
| Metric | SCCO | MCK |
|---|---|---|
| Price | $188.05 | $823.91 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 10 | 13 |
| Target Price | $124.28 | ★ $882.69 |
| AVG Volume (30 Days) | ★ 1.9M | 500.5K |
| Earning Date | 02-11-2026 | 02-04-2026 |
| Dividend Yield | ★ 1.94% | 0.40% |
| EPS Growth | 25.54 | ★ 66.19 |
| EPS | 4.67 | ★ 32.12 |
| Revenue | $12,334,600,000.00 | ★ $387,094,000,000.00 |
| Revenue This Year | $15.74 | $14.84 |
| Revenue Next Year | $6.81 | $8.33 |
| P/E Ratio | $39.43 | ★ $25.54 |
| Revenue Growth | 12.70 | ★ 17.23 |
| 52 Week Low | $72.75 | $570.51 |
| 52 Week High | $191.22 | $895.58 |
| Indicator | SCCO | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 71.64 | 49.20 |
| Support Level | $174.45 | $810.67 |
| Resistance Level | $191.22 | $847.90 |
| Average True Range (ATR) | 6.86 | 16.82 |
| MACD | 1.03 | -0.61 |
| Stochastic Oscillator | 88.22 | 41.63 |
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. It generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.